Literature DB >> 8164744

Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases.

M Allaire1, M M Chernaia, B A Malcolm, M N James.   

Abstract

The picornavirus family includes several pathogens such as poliovirus, rhinovirus (the major cause of the common cold), hepatitis A virus and the foot-and-mouth disease virus. Picornaviral proteins are expressed by direct translation of the genomic RNA into a single, large polyprotein precursor. Proteolysis of the viral polyprotein into the mature proteins is assured by the viral 3C enzymes, which are cysteine proteinases. Here we report the X-ray crystal structure at 2.3 A resolution of the 3C proteinase from hepatitis A virus (HAV-3C). The overall architecture of HAV-3C reveals a fold resembling that of the chymotrypsin family of serine proteinases, which is consistent with earlier predictions. Catalytic residues include Cys 172 as nucleophile and His 44 as general base. The 3C cleavage specificity for glutamine residues is defined primarily by His 191. The overall structure suggests that an intermolecular (trans) cleavage releases 3C and that there is an active proteinase in the polyprotein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164744     DOI: 10.1038/369072a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.

Authors:  D A Matthews; P S Dragovich; S E Webber; S A Fuhrman; A K Patick; L S Zalman; T F Hendrickson; R A Love; T J Prins; J T Marakovits; R Zhou; J Tikhe; C E Ford; J W Meador; R A Ferre; E L Brown; S L Binford; M A Brothers; D M DeLisle; S T Worland
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Identification of tolerated insertion sites in poliovirus non-structural proteins.

Authors:  Natalya L Teterina; Chris Lauber; Kenneth S Jensen; Eric A Levenson; Alexander E Gorbalenya; Ellie Ehrenfeld
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

3.  Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.

Authors:  Jing Wang; Tingting Fan; Xue Yao; Zhiqiang Wu; Li Guo; Xiaobo Lei; Jianwei Wang; Meitian Wang; Qi Jin; Sheng Cui
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 4.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

Review 5.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

6.  Analysis of the VPg-proteinase (NIa) encoded by tobacco etch potyvirus: effects of mutations on subcellular transport, proteolytic processing, and genome amplification.

Authors:  M C Schaad; R Haldeman-Cahill; S Cronin; J C Carrington
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  A homology identification method that combines protein sequence and structure information.

Authors:  L Yu; J V White; T F Smith
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

8.  3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.

Authors:  C Wirblich; M Sibilia; M B Boniotti; C Rossi; H J Thiel; G Meyers
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  The Nerium oleander aphid Aphis nerii is tolerant to a local isolate of Aphid lethal paralysis virus (ALPV).

Authors:  Aviv Dombrovsky; Neta Luria
Journal:  Virus Genes       Date:  2012-11-16       Impact factor: 2.332

10.  Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein.

Authors:  Muge Kuyumcu-Martinez; Gaël Belliot; Stanislav V Sosnovtsev; Kyeong-Ok Chang; Kim Y Green; Richard E Lloyd
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.